DK1039802T3 - Transdermal terapeutisk anordning med capsicin og capsaicinanaloger - Google Patents
Transdermal terapeutisk anordning med capsicin og capsaicinanalogerInfo
- Publication number
- DK1039802T3 DK1039802T3 DK98962908T DK98962908T DK1039802T3 DK 1039802 T3 DK1039802 T3 DK 1039802T3 DK 98962908 T DK98962908 T DK 98962908T DK 98962908 T DK98962908 T DK 98962908T DK 1039802 T3 DK1039802 T3 DK 1039802T3
- Authority
- DK
- Denmark
- Prior art keywords
- capsaicin
- capsicin
- therapeutic device
- transdermal therapeutic
- capsaicin analogues
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/990,633 US6239180B1 (en) | 1995-11-08 | 1997-12-15 | Transdermal therapeutic device and method with capsaicin and capsaicin analogs |
PCT/US1998/025794 WO1999030560A1 (fr) | 1997-12-15 | 1998-12-08 | Dispositif therapeutique transdermique et procede recourant a la capsaicine et a ses analogues |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1039802T3 true DK1039802T3 (da) | 2003-09-22 |
Family
ID=25536360
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98962908T DK1039802T3 (da) | 1997-12-15 | 1998-12-08 | Transdermal terapeutisk anordning med capsicin og capsaicinanaloger |
DK03005137T DK1316308T3 (da) | 1997-12-15 | 1998-12-08 | Transdermalt terapeutisk plaster med capsaicin og capsaicin-analoger |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03005137T DK1316308T3 (da) | 1997-12-15 | 1998-12-08 | Transdermalt terapeutisk plaster med capsaicin og capsaicin-analoger |
Country Status (11)
Country | Link |
---|---|
US (2) | US6239180B1 (fr) |
EP (2) | EP1316308B1 (fr) |
AT (2) | ATE240723T1 (fr) |
CA (1) | CA2314326C (fr) |
CY (1) | CY1107582T1 (fr) |
DE (2) | DE69836352T2 (fr) |
DK (2) | DK1039802T3 (fr) |
ES (2) | ES2272827T3 (fr) |
HK (1) | HK1030853A1 (fr) |
PT (1) | PT1039802E (fr) |
WO (1) | WO1999030560A1 (fr) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6239180B1 (en) * | 1995-11-08 | 2001-05-29 | The Regents Of The University Of California | Transdermal therapeutic device and method with capsaicin and capsaicin analogs |
US6383511B1 (en) * | 1999-10-25 | 2002-05-07 | Epicept Corporation | Local prevention or amelioration of pain from surgically closed wounds |
GB2355934B (en) * | 1999-11-05 | 2003-11-05 | Lohmann Gmbh & Co Kg | Wound dressing |
AUPQ622600A0 (en) * | 2000-03-15 | 2000-04-06 | Unisearch Limited | Treatment and/or prevention of ocular pain |
DE10056009A1 (de) * | 2000-11-11 | 2002-05-16 | Beiersdorf Ag | Hautfreundliches Wirkstoffpflaster zur transdermalen Verabreichung hyperämisierender Wirkstoffe |
US8110217B2 (en) * | 2001-08-13 | 2012-02-07 | University Of Pittsburgh | Sphingomyelin liposomes for the treatment of hyperactive bladder disorders |
US7063860B2 (en) * | 2001-08-13 | 2006-06-20 | University Of Pittsburgh | Application of lipid vehicles and use for drug delivery |
US20030125347A1 (en) * | 2001-11-02 | 2003-07-03 | Elan Corporation Plc | Pharmaceutical composition |
EP1539124B1 (fr) * | 2002-09-05 | 2018-07-18 | Vanderbilt Royalty Sub L.P. | Compositions et kits pour l'elimination de composes irritants de surfaces corporelles |
EP1551402A4 (fr) * | 2002-09-23 | 2009-05-27 | Verion Inc | Compositions pharmaceutiques n'induisant pas l'abus |
US7687080B2 (en) * | 2002-11-25 | 2010-03-30 | Taraxos Inc. | Treatment of neuropathy |
US20040191338A1 (en) * | 2002-12-18 | 2004-09-30 | Algorx | Administration of capsaicinoids |
US20050020690A1 (en) | 2002-12-18 | 2005-01-27 | Algorx | Infiltration of capsaicin into surgical sites and open wounds |
US7235270B2 (en) | 2003-03-10 | 2007-06-26 | Mayeux Jerry V | Pain balm |
AU2004230915B2 (en) * | 2003-04-08 | 2008-08-07 | Algorx Pharmaceuticals, Inc. | Preparation and purification of synthetic capsaicin |
EP1610742B1 (fr) * | 2003-04-10 | 2015-01-21 | Neurogesx, Inc. | Utilisation et compositions pour l'administration de la capsaïcine |
PT1613297E (pt) * | 2003-04-14 | 2007-08-23 | Lohmann Therapie Syst Lts | Emplastro terapêutico com matriz de polissiloxano compreendendo capsaicina |
DE102004009904A1 (de) * | 2004-02-26 | 2005-09-22 | Grünenthal GmbH | Kit aus einem gegebenenfalls wirkstoffhaltigen Pflaster und einem Hautirritationen verhindernden Mittel |
CA2569155A1 (fr) * | 2004-06-02 | 2005-12-15 | Sri International | Formulations contenant un casaicinoide, un anesthesiant local et/ou un agent antipruritique pour le traitement de la douleur |
US7704522B2 (en) | 2004-09-08 | 2010-04-27 | Clyde Morgan | Topical medicament |
EA200701131A1 (ru) * | 2004-11-24 | 2007-12-28 | Алгоркс Фармасьютикалз, Инк. | Гелеобразная препаративная форма капсаициноида и способы её применения |
JP2006206471A (ja) * | 2005-01-26 | 2006-08-10 | Nitto Denko Corp | テープ製剤 |
US20060204561A1 (en) * | 2005-02-14 | 2006-09-14 | Naweed Muhammad | Device for delivery of TRPV1 agonists |
WO2006099541A2 (fr) * | 2005-03-15 | 2006-09-21 | Richard Daniel Carliss | Produit therapeutique pour soigner les blessures |
EP1865933B1 (fr) * | 2005-03-30 | 2015-11-04 | Vanderbilt Royalty Sub L.P. | Timbre transdermique a faible concentration de capsaicine et procedes de traitement des douleurs neuropathiques |
WO2006107723A1 (fr) * | 2005-04-01 | 2006-10-12 | Neurogesx, Inc. | Huiles de capsaicinoides et leurs methodes de conception et d'utilisation |
US7282224B1 (en) | 2006-06-09 | 2007-10-16 | Guthy-Renker Corporation | Pain relief composition |
US7943666B2 (en) * | 2006-07-24 | 2011-05-17 | Trinity Laboratories, Inc. | Esters of capsaicin for treating pain |
US7645767B2 (en) * | 2006-08-31 | 2010-01-12 | Trinity Laboratories, Inc. | Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy |
US20080107747A1 (en) * | 2006-10-23 | 2008-05-08 | Roederer Joy E | Pain relief composition |
EP2276420B1 (fr) | 2008-04-04 | 2021-10-06 | Journey1, Inc. | Dispositif pour traiter un oeil ayant un épithélium défectueux |
US8987328B2 (en) * | 2008-10-30 | 2015-03-24 | Trinity Laboratories, Inc. | Esters of capsaicinoids as dietary supplements |
NO2490635T3 (fr) | 2009-10-23 | 2018-02-03 | ||
US8591025B1 (en) | 2012-09-11 | 2013-11-26 | Nexisvision, Inc. | Eye covering and refractive correction methods for LASIK and other applications |
US9498385B2 (en) | 2009-10-23 | 2016-11-22 | Nexisvision, Inc. | Conformable therapeutic shield for vision and pain |
WO2012061160A1 (fr) | 2010-10-25 | 2012-05-10 | Nexisvision, Inc. | Procédés et appareils pour identifier des éléments de recouvrement des yeux pour la vue |
US12044905B2 (en) | 2011-04-28 | 2024-07-23 | Journey1 Inc | Contact lenses for refractive correction |
JP2014514613A (ja) | 2011-04-28 | 2014-06-19 | ネクシスビジョン, インコーポレイテッド | 涙流、快適性、および/または適用性が改善された、眼被覆物および屈折矯正法および装置 |
WO2014210186A2 (fr) | 2013-06-26 | 2014-12-31 | Nexisvision, Inc. | Lentilles de contact pour correction réfractive |
US9423632B2 (en) | 2012-04-20 | 2016-08-23 | Nexisvision, Inc. | Contact lenses for refractive correction |
US8889659B2 (en) | 2011-09-09 | 2014-11-18 | Api Genesis, Llc | Pain relief compositions, manufacture and uses |
US9465233B2 (en) | 2012-04-20 | 2016-10-11 | Nexisvision, Inc. | Bimodular contact lenses |
US9498461B2 (en) | 2012-05-23 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
AU2013264896A1 (en) | 2012-05-23 | 2014-11-27 | Cellixbio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9341864B2 (en) | 2013-11-15 | 2016-05-17 | Nexisvision, Inc. | Contact lenses having a reinforcing scaffold |
WO2015116559A1 (fr) | 2014-01-29 | 2015-08-06 | Nexisvision, Inc. | Lentilles de contact bimodules multifocales |
WO2015160941A1 (fr) | 2014-04-15 | 2015-10-22 | Vizuri Health Sciences Llc | Compositions topiques pour le soulagement de la douleur, leur fabrication et leur utilisation |
SG11201706952VA (en) | 2014-09-26 | 2017-10-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of epilepsy and neurological disorders |
JP6698643B2 (ja) | 2014-09-29 | 2020-05-27 | セリックス バイオ プライヴェート リミテッドCellix Bio Private Limited | 多発性硬化症の治療のための組成物及び方法 |
CN107108535B (zh) | 2014-10-27 | 2020-04-28 | 塞尔利克斯生物私人有限公司 | 用于治疗多发性硬化的富马酸单甲酯与哌嗪或乙二胺的三组分盐 |
WO2016067297A1 (fr) | 2014-10-27 | 2016-05-06 | Cellix Bio Private Limited | Sels de l'acide valproïque associés à des dérivés aminés de la pipérazine, l'éthylènediamine, la lysine et/ou l'acide eicosapentaénoïque (epa) pour le traitement de l'épilepsie |
WO2016088132A1 (fr) | 2014-12-01 | 2016-06-09 | Cellix Bio Private Limited | Compositions et méthodes pour le traitement de la sclérose en plaques |
CA2976187A1 (fr) | 2015-02-09 | 2016-08-18 | Cellix Bio Private Limited | Sels de benzydamine et compositions connexes utiles pour le traitement de la mucosite |
WO2017020125A1 (fr) | 2015-07-31 | 2017-02-09 | Delivra Inc. | Préparations transdermiques pour administration de capsaïcinoïdes |
NZ750126A (en) | 2016-08-11 | 2022-07-01 | Cellix Bio Private Ltd | Compositions and methods for the treatment of irritable bowel syndrome |
CA3039125A1 (fr) | 2016-10-04 | 2018-04-12 | Cellix Bio Private Limited | Compositions et methodes pour le traitement de la xerostomie |
WO2018115984A1 (fr) | 2016-12-19 | 2018-06-28 | Cellix Bio Private Limited | Compositions et méthodes pour le traitement d'une inflammation |
BR112020001748A2 (pt) | 2017-07-27 | 2020-07-21 | Allergan, Inc. | agonistas de receptor de prostaciclina para redução de gordura corporal |
RU2761436C1 (ru) | 2017-11-17 | 2021-12-08 | Целликс Био Прайвет Лимитед | Композиции и способы лечения нарушений со стороны органа зрения |
AU2018369853B2 (en) | 2017-11-17 | 2022-07-14 | Cellix Bio Private Limited | Compounds, compositions and methods for treatment of eye disorders and skin diseases |
JP2023517745A (ja) | 2020-03-17 | 2023-04-26 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 初期非応答者を治療するためのカプサイシンパッチの繰り返しの局所適用 |
US20230310351A1 (en) | 2020-04-03 | 2023-10-05 | Gruenenthal Gmbh | Regimen for repeated topical application of capsaicin patch |
RU2755206C1 (ru) | 2020-05-20 | 2021-09-14 | Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) | Средство пролонгированного анальгетического действия и лекарственный препарат на его основе |
US11234947B2 (en) * | 2020-06-30 | 2022-02-01 | Imperial College Innovations Limited | Treatment of peripheral neuropathy induced by cancer chemotherapy |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4486450B1 (en) | 1980-07-14 | 1998-07-28 | Joel E Bernstein | Method of treating psoriatic skin and composition |
US4313958A (en) | 1980-10-24 | 1982-02-02 | The Procter & Gamble Company | Method of producing analgesia |
US4424205A (en) | 1982-03-18 | 1984-01-03 | The Procter & Gamble Company | Hydroxyphenylacetamides having analgesic and anti-irritant activity |
US4536404A (en) | 1983-06-16 | 1985-08-20 | Dermatological Enterprises, Ltd. | Method and composition for treating post-herpetic neuralgia |
US4532139A (en) | 1983-07-14 | 1985-07-30 | The Procter & Gamble Company | Compounds and compositions useful for producing analgesia |
US4544669A (en) | 1983-07-14 | 1985-10-01 | The Procter & Gamble Company | Compounds and compositions useful for producing analgesia |
US4544668A (en) | 1983-07-14 | 1985-10-01 | The Procter & Gamble Company | Compounds and compositions useful for producing analgesia |
US4592912A (en) | 1983-10-31 | 1986-06-03 | Harriet Nickolaus | Ache and pain relieving and preventing composition |
US4681897A (en) | 1984-01-16 | 1987-07-21 | The Procter & Gamble Company | Pharmaceutical products providing enhanced analgesia |
US4898887A (en) * | 1984-12-20 | 1990-02-06 | The Procter & Gamble Company | Compounds and compositions having anti-inflammatory and analgesic activity |
US4971800A (en) | 1988-07-08 | 1990-11-20 | The Regents Of The University Of California | Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents |
US4939149A (en) | 1988-10-24 | 1990-07-03 | The United States Of America As Represented By The Department Of Health And Human Services | Resiniferatoxin and analogues thereof to cause sensory afferent C-fiber and thermoregulatory desensitization |
US4997853A (en) | 1988-12-02 | 1991-03-05 | Galenpharma, Inc. | Method and compositions utilizing capsaicin as an external analgesic |
CA1338779C (fr) | 1989-03-17 | 1996-12-10 | Harry Hind | Methode pour traiter les douleurs associees au zona et les nevralgies post-zona grace a l'application topique d'anesthesiques locaux |
US5411738A (en) | 1989-03-17 | 1995-05-02 | Hind Health Care, Inc. | Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine |
WO1990014083A1 (fr) | 1989-05-15 | 1990-11-29 | Afferon Corporation | Composition et procede de desensibilisation neurale |
US5063060A (en) | 1989-12-19 | 1991-11-05 | Cisco Limited Partnership | Compositions and method for treating painful, inflammatory or allergic disorders |
JP2748199B2 (ja) * | 1991-08-27 | 1998-05-06 | 泰一郎 岩倉 | 気管支喘息発作の予防と治療貼付剤 |
US5260313A (en) | 1992-03-12 | 1993-11-09 | National Pain Institute, Inc. | Diagnosis and treatment of various neuralgias |
US5431914A (en) | 1992-04-17 | 1995-07-11 | Adekunle; Michael | Method of treating an internal condition by external application of capsaicin without the need for systemic absorption |
JP3414423B2 (ja) * | 1992-11-27 | 2003-06-09 | 積水化学工業株式会社 | 眠気防止用外用剤及び貼付剤 |
US5665360A (en) | 1993-05-14 | 1997-09-09 | Mann; Richard H. | Method of treating peripheral neuropathies of the feet and legs |
US5910512A (en) | 1994-04-18 | 1999-06-08 | Healthline Laboratories, Inc. | Topical analgesic using water soluble capsaicin |
DE4414502A1 (de) * | 1994-04-26 | 1995-11-02 | Edda Scholten | Salbe zur äußerlichen Anwendung bei Schmerzen |
US5665378A (en) | 1994-09-30 | 1997-09-09 | Davis; Roosevelt | Transdermal therapeutic formulation |
US5762963A (en) | 1995-06-07 | 1998-06-09 | Emory University | Method and compositions for controlling oral and pharyngeal pain using capsaicinoids |
US5788982A (en) | 1995-06-16 | 1998-08-04 | Nadoolman; Wolffe | Method and composition for treating oral pain using capsaicin |
US6239180B1 (en) * | 1995-11-08 | 2001-05-29 | The Regents Of The University Of California | Transdermal therapeutic device and method with capsaicin and capsaicin analogs |
US5854291A (en) | 1996-04-23 | 1998-12-29 | Medical Merchandising, Inc. | Pain reliever and method of use |
US5856361A (en) | 1996-04-23 | 1999-01-05 | Medical Merchandising, Inc. | Pain reliever and method of use |
US5869533A (en) | 1996-04-23 | 1999-02-09 | Holt; Stephen D. | Non-irritating capsaicin formulations and applicators therefor |
EP1201241B8 (fr) | 1997-03-13 | 2010-10-27 | James N. Campbell | Compositions contenant de la capsaicine ou des analogues de capsaicine et un anesthésique |
AU2466799A (en) | 1998-01-22 | 1999-08-09 | Regents Of The University Of California, The | Nucleic acid sequences encoding capsaicin receptors |
KR20060085258A (ko) | 1998-02-24 | 2006-07-26 | 웨이크 포리스트 유니버시티 | 만성 통증 및 여성에 특유한 통증을 비롯한 통증의 치료방법 |
-
1997
- 1997-12-15 US US08/990,633 patent/US6239180B1/en not_active Expired - Lifetime
-
1998
- 1998-12-08 DE DE69836352T patent/DE69836352T2/de not_active Expired - Lifetime
- 1998-12-08 WO PCT/US1998/025794 patent/WO1999030560A1/fr active IP Right Grant
- 1998-12-08 PT PT98962908T patent/PT1039802E/pt unknown
- 1998-12-08 DK DK98962908T patent/DK1039802T3/da active
- 1998-12-08 DK DK03005137T patent/DK1316308T3/da active
- 1998-12-08 DE DE69814917T patent/DE69814917T2/de not_active Expired - Lifetime
- 1998-12-08 EP EP03005137A patent/EP1316308B1/fr not_active Expired - Lifetime
- 1998-12-08 AT AT98962908T patent/ATE240723T1/de active
- 1998-12-08 ES ES03005137T patent/ES2272827T3/es not_active Expired - Lifetime
- 1998-12-08 AT AT03005137T patent/ATE344023T1/de active
- 1998-12-08 CA CA002314326A patent/CA2314326C/fr not_active Expired - Lifetime
- 1998-12-08 EP EP98962908A patent/EP1039802B1/fr not_active Expired - Lifetime
- 1998-12-08 ES ES98962908T patent/ES2196640T3/es not_active Expired - Lifetime
-
2001
- 2001-01-25 US US09/769,596 patent/US20010002406A1/en not_active Abandoned
- 2001-02-28 HK HK01101441A patent/HK1030853A1/xx not_active IP Right Cessation
-
2007
- 2007-01-25 CY CY20071100093T patent/CY1107582T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2196640T3 (es) | 2003-12-16 |
DE69814917T2 (de) | 2004-02-12 |
DE69836352T2 (de) | 2007-05-24 |
EP1316308A1 (fr) | 2003-06-04 |
US6239180B1 (en) | 2001-05-29 |
DE69814917D1 (de) | 2003-06-26 |
EP1316308B1 (fr) | 2006-11-02 |
EP1039802A1 (fr) | 2000-10-04 |
PT1039802E (pt) | 2003-10-31 |
ES2272827T3 (es) | 2007-05-01 |
EP1039802B1 (fr) | 2003-05-21 |
CY1107582T1 (el) | 2013-03-13 |
ATE240723T1 (de) | 2003-06-15 |
DE69836352D1 (de) | 2006-12-14 |
ATE344023T1 (de) | 2006-11-15 |
CA2314326C (fr) | 2008-11-18 |
DK1316308T3 (da) | 2007-03-05 |
CA2314326A1 (fr) | 1999-06-24 |
WO1999030560A1 (fr) | 1999-06-24 |
HK1030853A1 (en) | 2001-05-25 |
US20010002406A1 (en) | 2001-05-31 |
EP1039802A4 (fr) | 2002-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1039802T3 (da) | Transdermal terapeutisk anordning med capsicin og capsaicinanaloger | |
DK1201241T3 (da) | Sammensætninger indeholdende capsaicin eller capsaicinanaloge og et bedøvelsesmiddel | |
GEP20002146B (en) | Therapeutic Peptide Derivatives | |
DK0480934T3 (da) | Lægemiddel, der indeholder ephedrin og koffein til behandling af overvægt | |
NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
IS4083A (is) | Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja | |
ATE140388T1 (de) | Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen | |
DE69213814D1 (de) | Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie | |
ES2166783T3 (es) | Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii. | |
DE69625682D1 (de) | Verfahren zur behandlung von entzündungen und zusammensetzungen dafür | |
NO995944D0 (no) | Anti-arrytmisk blanding og fremgangsmåter for behandling | |
ATE200617T1 (de) | Pharmazeutische zusammensetzungen zur transdermalen verabreichung von melatonin und/oder seine analoge | |
ATE126061T1 (de) | Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum. | |
MX9700967A (es) | Uso terapeutico de acetazolamida para el tratamiento de edema cerebral. | |
CY1108368T1 (el) | Διαδερμικη συσκευη φελοδιπινης και μεθοδοι | |
EA200600757A1 (ru) | Тетрапептид, регулирующий уровень глюкозы в крови при сахарном диабете | |
NO960866L (no) | Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler | |
RU95122262A (ru) | Способ лечения повреждений периферических нервов при травмах конечностей | |
UA28769A (uk) | Спосіб лікування променевих ушкоджень шкіри | |
UA32384A (uk) | Спосіб лікування пародонтиту |